To compel the Secretary to periodically update the mandatory guidelines for Federal workplace drug testing

(a) In general On an annual basis, the Secretary of Health and Human Services shall review and if necessary revise the Mandatory Guidelines for Federal Workplace Drug Testing Programs, established pursuant to section 503(a) of Public Law 100–71 (5 U.S.C. 7301 note), to expand the list of substances authorized for testing to include any such drugs which may not have been previously included, and which the Secretary believes should be included. (b) Publication of notice Upon completion of the revision required under subsection (a), the Secretary shall publish a final notice in the Federal Register of such revision.